Fixing Healthcare Podcast

Greetings and happy-ish New Year. If you’re here for the latest information on Omicron, check out episode #53 or tune in for episode #55 on January 18, 2022. For now, this (shortly after) New Year’s episode of Coronavirus: The Truth features something slightly different. Jeremy Corr and Dr. Robert Pearl are zooming out for a more comprehensive look back at the year that was along with a look ahead at what might transpire in the year that is. Take a deep breath and tune in for answers to the following [time stamped] questions: [0:56] How can listeners put the past 12 months in perspective? [02:28] What can we make of the divide in Covid-19 research based on political affiliation? [07:27] What were the most significant Covid-19 moments of 2021? [08:49] What can we predict will happen with Covid-19 in 2022? [13:19] How are parents reacting to the highly transmissible Omicron variant? [14:17] Will the new oral pills make a meaningful difference in the Covid-19 fight? [15:21] What about the next set of vaccines? [18:40] Predictions for how courts will rule on vaccine mandates? [20:13] What will the next big wave of infections teach us? [22:51] How is America’s heartland responding to Covid-19 now? [24:30] Who is to blame for our continued Covid-19 difficulties? [28:09] What are Dr. Pearl’s big Covid-19 predictions for 2022? This episode is available on Apple Podcasts, Google Play, Spotify and other podcast platforms. If you have coronavirus questions for the hosts, please visit the contact page or send us a message on Twitter or LinkedIn. *To ensure the credibility of this program, Coronavirus: The Truth refuses to accept sponsorship, outside funding sources or guests with any financial or personal conflicts of interest. The post CTT #54: What can we expect from Covid-19 in 2022? appeared first on Fixing Healthcare.

This week’s guest is Fixing Healthcare alum David Feinberg. In August 2021, Dr. Feinberg was named CEO of Cerner, a leading provider of “electronic health records” or EHRs. Just four months after Feinberg became CEO, and a little more than 24 hours ago, Cerner was acquired by database giant Oracle for an estimated $28.3 billion. In this interview (which took place before the Cerner-Oracle news broke), Dr. Feinberg offers insights into following: what makes Cerner so valuable, the company’s longstanding competition with Epic, the immense potential for EHRs as a healthcare solution, and the challenges that remain for doctors who want to spend more time with patients and less time on their computers. David Feinberg Interview Highlights On Epic vs. Cerner “Well, first of all, I said this really clearly to the [Cerner] board when they called me, my competition isn’t Epic. My competition is heart disease and suicide and opiates being misused and preventable illnesses and COVID. And I’ll do whatever’s possible to beat that competition. I have tremendous respect for Epic. Look, I’ve been a customer of Cerner and Epic. I’ve used the systems. I’ve used Meditech, I’ve used Athena. And I would say none of us, including Cerner, have built a tool that was really designed for the end user … If my family gets admitted to a hospital and they’re on a different system than Cerner, I want it to work. So I want all these systems to work. And if we really care about our communities, they need to work together.” On the troubled history of EHRs “When we think of electronic health records, the bill of goods we were all sold was this was going to solve a lot of problems. Now I think it’s been a heroic lift to get everything digitized, but in doing so we created some new problems around usability and we certainly haven’t realized the promise of what this was supposed to be. [EHRs] are not intuitive and easy to use, they’re not adding a lot … they haven’t really fixed underlying problems of making it easier to care for patients.” On Cerner 10 years from now “A decade from now I hope Cerner is seen as the foundation of data that is allowing doctors, nurses and families to be able to access data to better care for themselves. And I hope that that leads to a healthcare system that is much more equitable, much more cost effective, much easier, and convenient and more dignified.” On big-tech companies in healthcare “I think it’s going to be some of the big tech companies and some of the incumbents in healthcare realizing they got to [fix healthcare] together because for us, for example, we have the data, we have the trusted relationships. If you combined us with, and you can go through the list of Amazon or Microsoft, Oracle, Google, whoever, they have other expertise that when you bring it together could really get to that promise of what I think we all thought the electronic health record was supposed to do.” On how EHRs can lower healthcare costs Well, the [dollar] figure has to lower because if we don’t, we can’t build roads and schools and people won’t get wage increases and we’ll see a further gap between those that have, and those who don’t. I think it’s been the biggest crime in healthcare that we’ve allowed us, those of us in healthcare, that we’ve allowed this to happen … Using data to make better decisions around care is the way [Cerner] can help the most. So, hey, we’re expensive to put in. We got to prove that not only are we easy to use, which we’re not yet, but not only are we easy to use by using our tools, you’re able to care for more people, you’re able to drop the cost of your care, you’re able to make sure that nurses that are so expensive and so hard to get right now are just doing nursing and not worrying about working in an EHR as a data clerk. So that’s how I think we can join this solution and we’re totally committed to it.” On progress notes “The progress notes in the United States for patients are twice as long as the progress notes that they are in the rest of the world, even in the developed world, right? And so it’s not like our patients are sicker, although a lot of doctors always like to say that, it just means that we’ve added documentation that I’m certain isn’t adding value to care. It actually becomes so dense you can’t even find what you’re looking for if you’re a consultant or a doc taking over a case. So we’re really looking at how we can decrease it.” READ: Full transcript with David Feinberg  * * * Dr. Robert Pearl is the author of a new book about medicine’s invisible yet highly influential physician culture. Check out “Uncaring: How Physician Culture Is Killing Doctors & Patients.” Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify, Stitcher or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn. The post FHC #41: New Cerner CEO says Epic isn’t his biggest competitor appeared first on Fixing Healthcare.

CTT #53: How dangerous is Omicron, based on the latest data? Omicron, the mysterious new variant accounting for nearly 3 of every 4 new cases in the United States, is top of mind for Americans as 2021 draws to an end. The answers scientists seek about Omicron are slowly coming into clearer view. In this episode of Coronavirus: The Truth, hosts Jeremy Corr and Dr. Robert Pearl look at the most recent data and discuss: the known risks of Omicron compared to Delta, the effectiveness of vaccines and boosters against Omcrion, the effect of the new variant on vaccine rates and the latest on vaccine mandates. Tune in now for the latest, science-based answers to the following [time stamped] questions: [01:00] Each show begins with the most recent and relevant facts concerning the Covid-19 pandemic and its impact on American life. What’s happening and what does it mean? [05:23] What do scientists now know about Omicron risks? [07:10] What are the current vaccine and booster rates? [09:00] What’s the latest in public opinion on vaccine mandates? [13:04] Listener question. Several listeners wrote to ask for an update on the effectiveness of the current vaccines against Omicron. What do we know? [17:28] Discussion. Why aren’t people in nursing homes getting the attention or protection they need? What can be done? [19:21] How will year three of Covid-19 affect people’s mental health? [25:16] Where do vaccine mandates stand in the courts? [28:35] What’s good this week? [30:16] What’s the big non-Covid story this week? [33:09] Discussion. Which of the following poses the biggest U.S. threat: inflation, Covid-19, business challenges and educational difficulties? [35:28] Is Omicron both more transmissible and less lethal? This episode is available on Apple Podcasts, Google Play, Spotify and other podcast platforms. If you have coronavirus questions for the hosts, please visit the contact page or send us a message on Twitter or LinkedIn. *To ensure the credibility of this program, Coronavirus: The Truth refuses to accept sponsorship, outside funding sources or guests with any financial or personal conflicts of interest. The post CTT #53: How dangerous is Omicron, based on the latest data? appeared first on Fixing Healthcare.

Medical professionals and budding entrepreneurs love to talk about the technologies that will someday revolutionize patient care. Our guest on Fixing Healthcare is already funding and fashioning those technologies to meet the needs of today’s patients. Our guest, Vinod Khosla, is an entrepreneur, investor, technologist and founder of Khosla Ventures, a firm with investments in hundreds of startups across more than a dozen industries. In healthcare, Khosla has provided venture assistance to fast risers like Forward, OSCAR, ZocDoc and many others. He was also the founding CEO of Sun Microsystems. This show features case-studies galore: From AI-driven mental health and physical therapy services to a Covid-testing product that can also screen you for the top 20 different respiratory illnesses. You’ll hear about diagnostic tools that are delivering results five-times faster and 10-times cheaper. And you’ll learn about a $28 million primary-care startup that Khosla says could be the next big thing in rural and safety-net care. In this episode, Khosla gives advice to aspiring entrepreneurs and gets specific about the future of medicine, detailing which technologies he believes have a chance at achieving the most difficult of missions: fixing healthcare. Vinod Khosla Interview Highlights On tech improving global healthcare and U.S. healthcare “I’ll try and constrain it to the US healthcare system in terms of my answers, but I think it’s globally applicable and the solutions are the same, but with a different tilt and different cultural context. In the US, we have relatively better care, but it’s expensive. My personal view, the most expensive part of the system is expertise, and expertise can relatively be tamed with technology and AI. So, not everybody in the world can get an oncologist. We can capture some of that expertise, so each oncologist can do 10 times more patient care than they would on their own without that help. That applies broadly.” On reducing healthcare costs with technology “I am pretty optimistic that the most expensive conditions, take diabetes, cardiology, musculoskeletal, will be done in verticals outside of the healthcare system. Can you use a Livongo or a Hello Heart to reduce blood pressure by 20 millimeters without drugs? Could you do weight reduction by 8% with a digital first offering? I think that’s starting to happen … That will start to reduce the cost, and then specialists will only be needed when the condition is severe or exceptional.” On improving rural healthcare with technology “Wherever healthcare depends on deep expertise, which is generally expensive, think oncologists or a brain surgeon, and you can do it remotely, care quality will improve and care costs will decline and accessibility will improve because a patient won’t have to go from that small town in Iowa to a major medical center and travel for three days for an appointment. So, I do think that will happen and will be very, very beneficial.” The business implications of healthcare disruption “It’ll be newer players who adapt these technologies, disrupt the price points in economics and will slowly eat into traditional systems, (which) will go bankrupt. This is the model that happened with bookstores and Amazon. The bookstores ignored Amazon for a long, long time as it slowly ate into sales with its new model. Later, they adapted this model, but mostly too late.” On the role of venture capital in healthcare “Look, the venture business always over invests in hard categories. The characteristic of venture startups is most will lose money, but more money will be made than lost, which says a small percentage of these will win, but the winners will make more money than the losers lose. So, net-net, broadly, if somebody’s broadly invested, they’ll do well and make money on their investment. So, imagine after 89 billion, 80 billion gets lost. That money gets lost as investments, but the 9 billion turns into 900 billion, creates another Apple or Google. That’s the model of venture capital.” READ: Full transcript with Vinod Khosla * * * Dr. Robert Pearl is the author of a new book about medicine’s invisible yet highly influential physician culture. Check out “Uncaring: How Physician Culture Is Killing Doctors & Patients.” Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Google, Spotify, Stitcher or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn. The post FHC #40: How venture-backed tech is transforming U.S. healthcare appeared first on Fixing Healthcare.

This week, America has Omicron on the mind. Listeners flooded the CTT inbox with questions about the new variant. Among them: Is Omicron more transmissible or lethal than Delta? Are current vaccines effective against it? What is President Biden doing to control the new variant and what kinds of social restrictions should we expect in the months ahead? In this episode of Coronavirus: The Truth, Jeremy Corr and Dr. Robert Pearl discuss all things Omicron. Tune in now for the latest, science-based answers to the following [time stamped] questions: [01:00] Each show begins with the most recent and relevant facts concerning the Covid-19 pandemic and its impact on American life. What’s happening and what does it mean? [04:13] What do scientists know about the Omicron variant so far? [12:37] Are current vaccines/boosters effective against Omicron? [17:48] What do researchers know about the economic impact of Covid-19 on minority communities? [19:16] How can politicians and scientists contingency plan for Omicron? [20:13] What’s new with the Merck pill that patients start soon after becoming symptomatic with Covid-19? [23:35] How does Omicron affect the “endemic” scenario? [27:15] Any good news this week? [30:34] What is President Biden’s plan to control Omicron? [33:28] Are patient privacy fears warranted? [35:15] What’s the latest with international border closures due to Covid-19? This episode is available on Apple Podcasts, Google Play, Spotify and other podcast platforms. If you have coronavirus questions for the hosts, please visit the contact page or send us a message on Twitter or LinkedIn. *To ensure the credibility of this program, Coronavirus: The Truth refuses to accept sponsorship, outside funding sources or guests with any financial or personal conflicts of interest. The post CTT #52: What do scientists know about Omicron? appeared first on Fixing Healthcare.

Americans who’ve received two shots of Pfizer or Moderna, or the single-dose J&J vaccine, are considered “fully vaccinated” … for now. That could change, depending on the data, according to White House chief medical adviser Dr. Anthony Fauci. Already, some U.S. governors are pushing to update the definition to include boosters. Last week, CDC officials urged all adults to get a vaccine booster six months after completing their original vaccine regimen. In this episode of Coronavirus: The Truth, Jeremy Corr and Dr. Robert Pearl discuss vaccine booster rates in the United States, the possible definition change for “fully vaccinated,” and what the future may hold.  Tune in now for the latest, science-based answers to the following [time stamped] questions: [01:00] Each show begins with the most recent and relevant facts concerning the Covid-19 pandemic and its impact on American life. What’s happening and what does it mean? [05:54] What can Puerto Rico teach the rest of America about vaccinations? [08:23] Why are cases in Europe spiking despite high vaccination rates? [11:26] Why is Moderna battling the NIH over vaccine patent rights? [14:20] Where do labor union stand on vaccine mandates? [16:02] What’s the status of President Biden’s vaccine plan for large employers? [17:18] What’s the mental-health impact social distancing and isolation? [18:53] Will booster shots change our nation’s definition of “fully vaccinated”? [19:57] What’s good this week? [21:48] What’s this episode’s big non-Covid story? [28:15] How do patients feel about telehealth? [29:30] How is Singapore’s government punishing unvaccinated citizens? This episode is available on Apple Podcasts, Google Play, Spotify and other podcast platforms. If you have coronavirus questions for the hosts, please visit the contact page or send us a message on Twitter or LinkedIn. *To ensure the credibility of this program, Coronavirus: The Truth refuses to accept sponsorship, outside funding sources or guests with any financial or personal conflicts of interest. The post CTT #51: Will the definition of ‘fully vaccinated’ change with boosters? appeared first on Fixing Healthcare.

George Halverson was CEO of Health Partners in Minnesota for 18 years and CEO of Kaiser Permanente for 12. As a health-plan leader, he spent 30 years fixing healthcare. He was successful in large part because he rejected what most Americans believe about health insurance. Halvorson believes better and more affordable healthcare is possible when people stop blindly paying for it and start assuming the role of buyer. “I absolutely, totally believe that we have to become better purchasers of care as a country,” said Halvorson, who worked as CEO alongside Fixing Healthcare cohost Robert Pearl from 2002 to 2014 at Kaiser Permanente. “When we function as a buyer, not a payer, we end up with much better care. We can expect quality to improve. We can expect data to flow. We can expect teams to function.” In this interview, Halvorson talks about health plans and the role of buyers. He also touches on the brilliance of Medicare Advantage, the bleak outlook for solo-practice doctors, and ways to improve healthcare for America’s most vulnerable populations. George Halvorson Interview Highlights On buying (rather than paying) for healthcare “When we buy care as a package, when we buy care from plans, and when we expect the plans to deliver the care, we have a whole different leverage for purchasing. In that setting, we can expect quality to improve. We can expect data to flow. We can expect teams to function … Both Kaiser and Health Partners are care settings that deliver care in addition to insure care. And because of that and you know the results. We have half as many people with hospital admissions. We have far (fewer) people with asthma attacks. We end up with much better care because we can focus on the care and do a better job of care.” On the solo-practice doctor “When you’re a solo-practice doctor, and you’re just trying to keep up all by yourself, that’s really hard. There (are) 1,000 medical journals out there. But when you have a Health Partners or Permanente Medical Group, that group can keep up on all of the science, can distill the science, and then can pass the best current science onto all of the people on the care team. So, it’s really problematic to try to keep up with medical science outside of a group setting. But in a group setting, because of Permanente, Health Partners, Mayo Clinic do a really good job of keeping up. So I much prefer the model. I just think it makes huge sense. And I think the whole country needs to move in that direction.” On for-profit vs. not-for-profit health plans “Well, I think the differences between the not-for-profit and the for-profits were significantly greater a couple decades ago than they are now. As a not-for-profit health plan, we can focus on the wellbeing of the patient. I used to be chair of AHIP years ago. I was chair a couple times of the National Association of Insurance Companies and Health Plans. And one of the things, when we went down the path of improving quality in that context, we initially had some of the for-profit companies resisting going down that path. And they resisted because they had shareholder lawsuits, literally saying, ‘As shareholders, that those health plans should not be improving quality. They should be optimizing profit.’” On Optum following the Kaiser Permanente playbook “Optum right now is trying really hard. Their self-image is that they’re going to deliver great and continuously improving care. That’s part of what they’re trying to push in their culture. And that’s also part of their market model. So, they have gone far down that road. And I know for a fact that the folks at Optum have studied Kaiser Permanente, studied stuff that you (Robert Pearl) had invented. They’re moving it into their setting. But they’re doing it with the belief that they will thrive over time by being best in care and not just best on underwriting and risk selection.” On us vs. them in medical care “We are wired instinctively to divide the world into us and them. We figure out who’s an us, we figure out who is a them, and when someone is an us, we’re supportive, we’re enabling, we do good things for us. And when someone is a them we’re suspicious, paranoid, territorial, distrustful. In healthcare, we end up with all kinds of negative consequences, unintended consequences by many well-meaning people who diagnose differently, or treat differently, or prescribe differently, and also who literally don’t trust.” On President Biden’s healthcare agenda “He should make the Medicaid part of his agenda really clear. And a lot of the people who are opposed to him, politically, a disproportionate number of them need Medicaid and need to have a sense of that he is helping, steering them in that direction. I think on the Medicare side, the pure classic Medicare for all model has some support with some elements in the party, but it does not have support with the vast majority of Democrats. Unions don’t like it at all, because unions actually provide healthcare in good ways for their members.” READ: Full transcript with George Halvorson  * * * Dr. Robert Pearl is the author of a new book about medicine’s invisible yet highly influential physician culture. Check out “Uncaring: How Physician Culture Is Killing Doctors & Patients.” Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Google, Spotify, Stitcher or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn. The post FHC #39: Paying for healthcare is out. Buying healthcare is in. appeared first on Fixing Healthcare.

There was time when Coronavirus: The Truth cohosts Jeremy Corr and Dr. Robert Pearl assumed the show would be irrelevant and retired by episode 20. This week, which marks the show’s 50th episode, the question must be asked: Is the coronavirus here to stay? Several news outlets have reported in recent weeks that the Covid-19 pandemic may become endemic, continuing to circulate among the population for the foreseeable future. If that were to happen, according to the Wall Street Journal, “The disease could eventually become more similar to routine illnesses like the flu or colds, common ailments that are less destructive and deadly than Covid-19 is now.” So, with vaccinations rates stalling and herd immunity still a long way off, Pearl and Corr discuss whether some form of Covid-19 be with us for the long haul. That and the following [time stamped] questions now: [01:01] Each show begins with the most recent and relevant facts concerning the Covid-19 pandemic and its impact on American life. What’s happening and what does it mean? [04:45] Listener question: “I’ve been fully vaccinated and was wondering about getting a booster since there has been so much debate about approving additional shots for people under the age of 65.” [06:46] Merck’s Covid-19 pill is now approved in Great Britain. What’s the story here? [10:25] Do we need vaccine mandates? [12:31] What should parents know about vaccinated their children? [13:48] Question for cohost Jeremy Corr: If you knew in March 2020 this pandemic would be a 2-3 year march, is there anything you would have done differently for yourself or your son? [15:50] Listener question: “I have recovered from Covid-19. How important is it to be vaccinated in addition? I’m worried about having a reaction to the shot. [18:18] Will the Covid-19 pandemic become endemic? And what would that mean?   [23:42] Do poor Americans suffer more in a pandemic? [25:09] Did financial incentives increase vaccinations as hoped? [26:48] What’s good this week? [28:48] What’s this episode’s non-Covid healthcare story? [32:01] What’s coming up on the Fixing Healthcare podcast? [33:35] Should parents vaccinate the five- and six-year-olds? This episode is available on Apple Podcasts, Google Play, Spotify and other podcast platforms. If you have coronavirus questions for the hosts, please visit the contact page or send us a message on Twitter or LinkedIn. *To ensure the credibility of this program, Coronavirus: The Truth refuses to accept sponsorship, outside funding sources or guests with any financial or personal conflicts of interest. The post CTT #50: Is Covid-19 here to stay? appeared first on Fixing Healthcare.

In this episode of Coronavirus: The Truth, Jeremy Corr and Dr. Robert Pearl tackle more than a dozen timely and tricky Covid-19 questions. This week: What should listeners know about the upcoming holiday season and Covid travel restrictions? Has the Biden administration provided any clarity on the vaccine mandate for employers? How did Puerto Rico manage to out-vaccinate every American state? And, finally, one listener asks: Can I get a flu shot and Covid-19 booster at the same time? Dr. Pearl responds at the bottom of the broadcast by noting the heightened risks of influenza this year, given the dramatic decline in cases during the 2020 flu season. He also dives into the CDC’s guidance for people hoping to double up their flu and booster shots at the pharmacy or doctor’s office. Tune in for answers to this and other (time-stamped) questions on Coronavirus: The Truth. [01:01] Each show begins with the most recent and relevant facts concerning the Covid-19 pandemic and its impact on American life. What’s happening and what does it mean? [04:46] Vaccine boosters: Who’s eligible for which one? Should J&J recipients mix and match? [06:49] Where do things stand with international ground and air travel restrictions? [10:05] With the 50th episode coming up, what stands out about the past 18 months to CTT hosts Jeremy Corr and Dr. Robert Pearl? [11:30] What lessons can we learn from Gen. Colin Powell’s death? [14:55] What are Biden’s three strategic options in the battle against Covid-19? [18:18] Do we need to vaccinate kids in order to reach the 90% threshold for herd immunity? [21:54] What’s the relationship between a vaccinated person’s age and chances of dying? [23:49] How did Puerto Rico achieve such a high level of vaccination? [26:09] What’s this episode’s big non-Covid healthcare story? [29:09] Will families celebrate the holidays differently this year vs. last? [30:08] Listener question: Flu season is about to begin, so can I get a booster for Covid-19 and a flu shot on the same day? This episode is available on Apple Podcasts, Google Play, Spotify and other podcast platforms. If you have coronavirus questions for the hosts, please visit the contact page or send us a message on Twitter or LinkedIn. *To ensure the credibility of this program, Coronavirus: The Truth refuses to accept sponsorship, outside funding sources or guests with any financial or personal conflicts of interest. The post CTT #49: Can I get my flu shot and Covid-19 booster at the same time?  appeared first on Fixing Healthcare.

Merck’s new oral antiviral medication (molnupiravir) has been labeled a “huge, huge advance” in the fight against Covid-19 by a Harvard Medical School virologist. The pill also has been called the “holy grail of treatments” by an executive director at the World Health Organization. Merck says it’s now seeking FDA authorization of the investigational medication after phase-three clinical trials showed a 50% reduction in hospitalizations and death among individuals infected with Covid-19. In this episode of Coronavirus: The Truth, Jeremy Corr and Dr. Robert Pearl discuss the new medication, the research done so far, the pill’s side effects, the costs, and the implications for our nation’s ongoing battle against the coronavirus. [01:00] What should we know about Merck’s new pill? [06:40] How do we explain those who are anti-vaccine but pro-Merck-pill despite the large differential in available research data? [07:55] Who should get a booster, according to FDA and CDC guidelines? [10:58] Are vaccine mandates working based on early returns? [12:42]  What prompted Dr. Pearl’s provocative Forbes article comparing Covid-19 with 9/11? [16:44] Listener question: Do we have any data regarding side-effects from booster shots? [18:12] What ever happened to Covid-19 testing? [21:10] Any scientific truth to social-media claims Covid-19 vaccines cause infertility [23:29] What’s good this week? [25:59] What’s the big non-Covid healthcare story listeners should know about? [31:10] Listener question: “I loved [Jeremy’s] analysis about which of the past U.S. presidents would have been best to lead our nation through the pandemic. I though your choice of Lincoln was superb. Who do you believe would have been the worst president for this task?” [34:12] What should we make of California Governor Gavin Newsome’s decision to require vaccination for in-person classes for all students in schools? This episode is available on Apple Podcasts, Google Play, Spotify and other podcast platforms. If you have coronavirus questions for the hosts, please visit the contact page or send us a message on Twitter or LinkedIn. *To ensure the credibility of this program, Coronavirus: The Truth refuses to accept sponsorship, outside funding sources or guests with any financial or personal conflicts of interest. The post CTT #48: Is Merck’s anti-Covid pill really the ‘holy grail’? appeared first on Fixing Healthcare.